Invivyd CSO Disposes of $58,600 in Stock as Company Advances Phase 3 Plans
Invivyd, Inc. (NASDAQ: IVVD) reported that Chief Scientific Officer Robert D. Allen III sold common stock totaling roughly $58,600 across two transactions on February 17 and 18, 2026. The sales - executed under a pre-arranged Rule 10b5-1 trading plan to satisfy tax liabilities triggered by RSU vesting - follow an option exercise earlier in the mont…